Rapid Dose Therapeutics Enters into Advisory Agreement with Spinnaker Capital Markets
February 14, 2019
BURLINGTON, Ontario – February 14, 2019 – Rapid Dose Therapeutics Corp. (“RDT”) (CSE: DOSE) is pleased to announce that it has appointed Spinnaker Capital Markets Inc. (“Spinnaker”) as its capital markets and investor relations advisor. Spinnaker is a Toronto-based advisory firm which provides public companies with an array of services tailored to raise capital, target and attract institutional and retail investors, increase shareholder value and focus on developing and expanding the network of investors, analysts and financial intermediaries who are interested in RDT.
The agreement is for an initial term of 12 months and provides for a full range of advisory and investor relations services for a monthly fee of $8,000. Pursuant to the agreement and subject to all regulatory and board approval, RDT agrees to grant 200,000 stock options which will vest on a quarterly basis over a 12 month period.
A Game-Changing Delivery System
About Rapid Dose Therapeutics
Rapid Dose Therapeutics Corp. is a publicly-traded Canadian biotechnology company that provides innovative, proprietary drug delivery technologies designed to improve outcomes and quality of lives. Through its wholly-owned subsidiary, Rapid Dose Therapeutics Inc., RDT offers Quick, Convenient, Precise and Discreet™ choices to consumers. RDT is focused and committed to clinical research and product development for the healthcare manufacturing industry — including nutraceutical, pharmaceutical and cannabis industries. Within the cannabis sector, RDT provides a turn-key Managed Strip Service Program which enables RDT’s QuickStrip™ proprietary drug delivery technology to be licensed by select partners. RDT’s service based annuity contracts drive recurring revenue which enables rapid expansion into emerging markets — generating value for consumers and shareholders. Rapid Dose Therapeutics is committed to continually create innovative solutions aimed at multiple consumer segments and future market needs.
For more information, visit: www.rapiddose.ca
For inquiries please contact:
Spinnaker Capital Markets Inc.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information in this news release may contain forward-looking information within the meaning of applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward- looking statements. Forward looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “potential”, “believe”, “intend” or the negative of these terms and similar expressions. Statements containing forward-looking information, including, without limitation, in respect of the delivery of products using the QuickStrip™ product delivery method, express, as at the date of this news release, the plans, estimates, forecasts, projections, expectations or beliefs of RDT as to future events or results and are believed to be reasonable based on information currently available to them. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving cannabis; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally, income tax and regulatory matters; the ability to implement its business strategies; competition; currency and interest rate fluctuations and other risks. Readers are cautioned that the foregoing list is not exhaustive. There can be no assurance that statements of forward-looking information, although considered reasonable by management at the time of preparation, will prove to be accurate as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. Actual results and future events could differ materially from those anticipated in such statements. Readers should not place undue reliance on forward-looking information. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
Back to press releases page